If guidance is achieved as seems likely($36-40M) for F'24 and with larger scale clinical studies to report throughout the year and beyond, the excellent sales team IV has assembled, the potential of this unique technology which is applicable across a broad spectrum of healthcare (TAM $12Billion) the potential of Next Science is unlimited.
Only wish I had more funds to invest....
- Forums
- ASX - By Stock
- NXS
- Ann: Next Science reports FY23 Result
Ann: Next Science reports FY23 Result, page-10
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NXS (ASX) to my watchlist
(20min delay)
|
|||||
Last
26.0¢ |
Change
-0.005(1.89%) |
Mkt cap ! $75.84M |
Open | High | Low | Value | Volume |
26.0¢ | 26.0¢ | 26.0¢ | $13.22K | 50.87K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 15572 | 26.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.5¢ | 2488 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 15572 | 0.260 |
1 | 2000 | 0.255 |
3 | 42039 | 0.250 |
3 | 87613 | 0.240 |
3 | 9939 | 0.230 |
Price($) | Vol. | No. |
---|---|---|
0.265 | 2488 | 1 |
0.270 | 25235 | 2 |
0.275 | 17850 | 2 |
0.280 | 13571 | 2 |
0.285 | 75660 | 1 |
Last trade - 12.44pm 19/06/2024 (20 minute delay) ? |
Featured News
NXS (ASX) Chart |
The Watchlist
INF
INFINITY LITHIUM CORPORATION LIMITED
Ryan Parkin, Managing Director & CEO
Ryan Parkin
Managing Director & CEO
Previous Video
Next Video
SPONSORED BY The Market Online